SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-19-011529
Filing Date
2019-04-12
Accepted
2019-04-12 17:30:48
Documents
8
Effectiveness Date
2019-04-12

Document Format Files

Seq Description Document Type Size
1 2019 DEFA14A snss-defa14a_20190412.htm DEFA14A 112629
2 GRAPHIC ginhvmyhiu0n000004.jpg GRAPHIC 1062
3 GRAPHIC ginhvmyhiu0n000007.jpg GRAPHIC 1035
4 GRAPHIC ginhvmyhiu0n000002.jpg GRAPHIC 2391
5 GRAPHIC ginhvmyhiu0n000003.jpg GRAPHIC 2391
6 GRAPHIC ginhvmyhiu0n000005.jpg GRAPHIC 2391
7 GRAPHIC ginhvmyhiu0n000006.jpg GRAPHIC 1063
8 GRAPHIC ginhvmyhiu0n000001.jpg GRAPHIC 1362
  Complete submission text file 0001564590-19-011529.txt   130997
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-51531 | Film No.: 19747127
SIC: 2834 Pharmaceutical Preparations